Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mad2 who wrote (2529)	4/20/2000 1:56:00 AM
From: DanZ	Respond to of 5582

Mad2, I read the entire press release very carefully several times. My interpretation can be found at messages.yahoo.com If you read the sentence that you posted without consideration for the rest of the press release, you can come to the wrong conclusion. I think that the stock will rally because I suspect that buyers have been scared that the ruling might go against Gum Tech. This could have contributed to a lack of bids, and the overall down market had a greater than normal effect on the stock. I believe that GUMM is trading at a ridiculously low valuation. When the stock got to 8 the other day, it was trading below the price when the news of Zicam first leaked. This means that the market was giving zero value (or even negative value) to Gel Tech, even though the company is in much better shape now than it was ~18 months ago when it last traded at 8.